[HTML][HTML] Recent advances in pathophysiology, drug development and future perspectives of SARS-CoV-2
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
[引用][C] Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi, DK Yadav - Frontiers in Cell and …, 2020 - jglobal.jst.go.jp
Abd El-Aziz TM Stockand JD (2020). Recent progress and challenges in drug development
against SARS-COV-2 coronavirus (SARS-CoV-2)-an update on the status. Infect. Genet …
against SARS-COV-2 coronavirus (SARS-CoV-2)-an update on the status. Infect. Genet …
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi… - Frontiers in cell and …, 2020 - pubmed.ncbi.nlm.nih.gov
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi, DK Yadav - 2020 - scholarworks.bwise.kr
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
[PDF][PDF] Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi, DK Yadav - scienceopen.com
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensinconverting …
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensinconverting …
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi… - Editor's Pick 2021 …, 2022 - books.google.com
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
Page 80 REVIEW published: 06 November 2020 doi: 10.3389/fcell. 2020.580202 Recent …
Page 80 REVIEW published: 06 November 2020 doi: 10.3389/fcell. 2020.580202 Recent …
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2.
DD Singh, I Han, EH Choi, DK Yadav - Frontiers in Cell and …, 2020 - europepmc.org
Abstract The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly
pathogenic disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin …
pathogenic disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin …
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi, DK Yadav - 2020 - agris.fao.org
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
[HTML][HTML] Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
DD Singh, I Han, EH Choi, DK Yadav - Frontiers in Cell and …, 2020 - ncbi.nlm.nih.gov
Abstract The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly
pathogenic disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin …
pathogenic disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin …